References
- Folkman J. Tumour angiogenesis: therapeutic implications. N Eng J Med 1971;285:1182–6.
- Folkman J. Tumour angiogenesis. Holland JF, Frej E. Ccancer medicine. Fifth edition. American Ccancer Society. Hamilton, Ontario; New York: B.C Decker Inc.; 2000. 132–52.
- Beer AJ, Niemeyer M, Carlsen J, Sarbia M, Nährig J, Watzlowik P . M. Patterns of αvβ3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET. J Nucl Med 2008;49:255–9.
- Falcioni R, Cimino L, Gentileschi MP, D'Agnano I, Zupi G, Kennel SJ, . Expression of beta 1, beta 3, beta 4 and beta 5 integrins by human lung carcinoma cells of different histotypes. Exp Cell Res 1994;210:113–22.
- Haubner R, Wester HJ, Weber WA, Mang C, Ziegler SI, Goodman SL, . Noninvasive imaging of αvβ3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res 2001;61:1781–5.
- Chen X, Park R, Tohme M, Shahinian AH, Bading JR, Conti PS. MicroPET and autoradiographic imaging of breast cancer αv integrin expression using 18F and 64 Cu-labeled RGD peptide. Bioconjugate Chem 2004;15:41–9.
- Fani M, Psimadas D, Zikos C, Xantopoulos S, Loudos GK, Bouziotis P, . Comparative evaluation of linear and cyclic 99mTc-RGD peptides for targeting of integrins in tumor angiogenesis. Anticancer Res 2006;26:431–4.
- Liu S, Hsieh WY, Jiang Y, Kim YS, Sreerama SG, Chen X, Jia B, . Evaluation of a 99mTc-labelled cyclic RGD tetramer for noninvasive imaging integrin αvβ3-positive breast cancer. Bioconjugate Chem 2007;18:438–46.
- Liu S. Radiolabeled multimeric cyclic RGD peptides as integrin αvβ3 targeted radiotracers for tumor imaging. Mol Pharmaceutics 2006;3:472–87.
- Bach-Gansmo T, Skretting A, Bogsrud TV. Integrin scintimammography using a dedicated breast imaging, solid-state γ-camera and 99mTc-labelled NC100692. Clin Phys Funct Imag 2008;28:235–9.
- Bach-Gansmo T, Danielsson R, Saracco A, Wilczek B, Bogsrud T, Fangberget A, . Integrin receptor imaging of breast cancer: a proof-of-concept study to evaluate 99m-Tc-NC100692. J Nucl Med 2006;47:1434–9.
- Edwards D, Jones P, Haramis H, Battle M, Lear R, Barnett DJ, . 99mTc-NC100692 – a tracer for imaging vitronectin receptors associated with angiogenesis: a preclinical investigation. Nucl Med Biol 2008;35:365–75.
- Haubner R, Weber WA, Beer AJ, Vabuliene E, Reim D, Sarbia M, . Noninvasive visualization of the activated αvβ3 integrin in cancer patients by positron emission tomography and [18F] Galacto-RGD. PloS Med 2005;2:e70. Epub 2005 March 29.
- Beer AJ, Lorenzen S, Metz S, Herrmann K, Watzlowik P, Wester HJ, . Comparison of integrin αvβ3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: 1 PET study using 18F-Galacto-RGD and 18F-FDG. J Nucl Med 2008;49:22–9.
- Beer AJ, Schwaiger M. Imaging of integrin αvβ3 expression. Cancer Metastases Rev 2008;27:631–44.
- Shi J, Wang L, Kim Y-S, Zhai S, Liu Z, Chen X, . Improving tumor uptake and excretion kinetics of Tc-labelled cyclic arginine-glycine-aspartic (RGD) dimers with triglycine linkers. J Med Chem 2008;51:7980–90.